Actuate Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutic agents for patients with cancer or inflammatory diseases. It has developed 9-ING-41 agent, which shows significant anti-tumor activity in many models of difficult-to-treat cancers, including cancers of the brain, pancreas, lung, breast, and lymphomas.